Variant report
Variant | esv1826300 |
---|---|
Chromosome Location | chr8:6825582-6827965 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:183)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr8:6825706-6825903 | K562 | blood: | n/a | chr8:6825850-6825859 chr8:6825848-6825857 chr8:6825847-6825860 chr8:6825849-6825858 chr8:6825843-6825864 chr8:6825849-6825858 |
2 | CTCF | chr8:6827929-6828105 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr8:6827960-6828110 | K562 | blood: | n/a | n/a |
4 | CTCF | chr8:6827880-6828030 | HEK293 | kidney: | n/a | chr8:6827881-6827890 chr8:6827923-6827930 |
5 | ELF1 | chr8:6826345-6826676 | GM12878 | blood: | n/a | n/a |
6 | MAFF | chr8:6825659-6825678 | K562 | blood: | n/a | n/a |
7 | MAFF | chr8:6825520-6825751 | HepG2 | liver: | n/a | chr8:6825656-6825674 |
8 | MAFK | chr8:6825667-6825713 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | MAFK | chr8:6825571-6825794 | HepG2 | liver: | n/a | n/a |
10 | MAFK | chr8:6825499-6825829 | HepG2 | liver: | n/a | n/a |
11 | MAFK | chr8:6825552-6825788 | IMR90 | lung: | n/a | n/a |
12 | RAD21 | chr8:6827832-6828150 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | SPI1 | chr8:6826228-6826651 | HL-60 | blood: | n/a | n/a |
14 | USF2 | chr8:6825797-6825900 | Hela-S3 | cervix: | n/a | chr8:6825850-6825859 chr8:6825848-6825857 chr8:6825847-6825860 chr8:6825849-6825858 chr8:6825843-6825864 chr8:6825847-6825858 chr8:6825849-6825858 |
15 | USF2 | chr8:6827155-6827365 | HepG2 | liver: | n/a | chr8:6827201-6827210 chr8:6827201-6827210 chr8:6827199-6827212 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6827800-6827850 | ECC-1 | luminal epithelium: | n/a |
2 | chr8:6827800-6827850 | HRPEpiC | eye: | n/a |
3 | chr8:6826392-6826442 | HAEpiC | amniotic membrane: | n/a |
4 | chr8:6826392-6826442 | NT2-D1 | testis: | n/a |
5 | chr8:6827814-6827864 | A549 | lung: | n/a |
6 | chr8:6827814-6827864 | NH-A | brain: | n/a |
7 | chr8:6826392-6826442 | SKMC | muscle: | n/a |
8 | chr8:6827814-6827864 | U87 | brain: | n/a |
9 | chr8:6827800-6827850 | Hepatocyte | liver: | n/a |
10 | chr8:6827800-6827850 | ProgFib | skin: | n/a |
11 | chr8:6827814-6827864 | H1-hESC | embryonic stem cell: | embryo |
12 | chr8:6827814-6827864 | HUVEC | blood vessel: | n/a |
13 | chr8:6827814-6827864 | HCF | heart: | n/a |
14 | chr8:6827814-6827864 | HCM | heart: | n/a |
15 | chr8:6827800-6827850 | ovcar-3 | ovarian: | n/a |
16 | chr8:6826392-6826442 | BE2_C | brain: | n/a |
17 | chr8:6826392-6826442 | NH-A | brain: | n/a |
18 | chr8:6826392-6826442 | PrEC | prostate: | n/a |
19 | chr8:6826392-6826442 | ovcar-3 | ovarian: | n/a |
20 | chr8:6827814-6827864 | GM19239 | blood: | n/a |
21 | chr8:6826392-6826442 | GM19239 | blood: | n/a |
22 | chr8:6827800-6827850 | HNPCEpiC | eye: | n/a |
23 | chr8:6827800-6827850 | HPAEpiC | pulmonary alveolar: | n/a |
24 | chr8:6827814-6827864 | GM06990 | blood: | n/a |
25 | chr8:6827814-6827864 | BJ | skin: | n/a |
26 | chr8:6827800-6827850 | NHBE | bronchial: | n/a |
27 | chr8:6827814-6827864 | MCF-7 | breast: | n/a |
28 | chr8:6826392-6826442 | Hepatocyte | liver: | n/a |
29 | chr8:6827814-6827864 | HIPEpiC | eye: | n/a |
30 | chr8:6826392-6826442 | A549 | lung: | n/a |
31 | chr8:6827800-6827850 | HepG2 | liver: | n/a |
32 | chr8:6827814-6827864 | LNCaP | prostate: | n/a |
33 | chr8:6826392-6826442 | SK-N-SH_RA | brain: | n/a |
34 | chr8:6827800-6827850 | HEEpiC | esophagus: | n/a |
35 | chr8:6827814-6827864 | ECC-1 | luminal epithelium: | n/a |
36 | chr8:6826392-6826442 | K562 | blood: | n/a |
37 | chr8:6827800-6827850 | HCF | heart: | n/a |
38 | chr8:6827800-6827850 | AoSMC | blood vessel: | n/a |
39 | chr8:6827800-6827850 | GM12878 | blood: | n/a |
40 | chr8:6827800-6827850 | NH-A | brain: | n/a |
41 | chr8:6826392-6826442 | Hela-S3 | cervix: | n/a |
42 | chr8:6827814-6827864 | AG09319 | gingival: | n/a |
43 | chr8:6826392-6826442 | AoSMC | blood vessel: | n/a |
44 | chr8:6827814-6827864 | AoSMC | blood vessel: | n/a |
45 | chr8:6827800-6827850 | MCF-7 | breast: | n/a |
46 | chr8:6827800-6827850 | IMR90 | lung: | fetal |
47 | chr8:6827814-6827864 | HEEpiC | esophagus: | n/a |
48 | chr8:6827814-6827864 | GM12891 | blood: | n/a |
49 | chr8:6827800-6827850 | HCT-116 | colon: | n/a |
50 | chr8:6827800-6827850 | PFSK-1 | brain: | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DEFA1-1 | chr8:6825663-6825775 | NONHSAT124803 |
2 | lnc-DEFA1-1 | chr8:6825663-6825769 | NONHSAT124802 |
3 | lnc-DEFA1-1 | chr8:6826461-6826635 | NONHSAT124803 |
4 | lnc-DEFA1-1 | chr8:6826452-6826635 | NONHSAT124802 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DEFA10P | TF binding region |
DEFA10P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140749438 | chr8:6825616-6825617 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181444926 | chr8:6825629-6825630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs184631703 | chr8:6825655-6825656 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143020111 | chr8:6825658-6825659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531128559 | chr8:6825661-6825662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117582969 | chr8:6825671-6825672 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs567330841 | chr8:6825678-6825679 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs536285071 | chr8:6825679-6825680 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs547066163 | chr8:6825680-6825681 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs76176806 | chr8:6825688-6825689 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs189750721 | chr8:6825718-6825719 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs181855629 | chr8:6825722-6825723 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs186047291 | chr8:6825725-6825726 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs535313882 | chr8:6825740-6825741 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs115726153 | chr8:6825743-6825744 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs372482670 | chr8:6825757-6825758 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs36110831 | chr8:6825770-6825771 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs139202523 | chr8:6825785-6825786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542306678 | chr8:6825794-6825795 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559379377 | chr8:6825810-6825811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572888528 | chr8:6825852-6825853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149920893 | chr8:6825853-6825854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549610135 | chr8:6825854-6825855 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531066105 | chr8:6825863-6825864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs13278390 | chr8:6825877-6825878 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs13270884 | chr8:6825885-6825886 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs13267882 | chr8:6825891-6825892 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs546710375 | chr8:6825897-6825898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73195997 | chr8:6825913-6825914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566922761 | chr8:6825958-6825959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532520579 | chr8:6825960-6825961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs13278672 | chr8:6825975-6825976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549190813 | chr8:6825996-6825997 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs13271399 | chr8:6825998-6825999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs13270339 | chr8:6826010-6826011 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191225676 | chr8:6826012-6826013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs13271426 | chr8:6826025-6826026 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2738144 | chr8:6826043-6826044 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13270374 | chr8:6826050-6826051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552712817 | chr8:6826056-6826057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13278935 | chr8:6826057-6826058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181781851 | chr8:6826060-6826061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544784192 | chr8:6826074-6826075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs71525777 | chr8:6826081-6826082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558268919 | chr8:6826084-6826085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs2978947 | chr8:6826089-6826090 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs148631801 | chr8:6826094-6826095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs71511146 | chr8:6826099-6826100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs71535994 | chr8:6826115-6826116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71525778 | chr8:6826140-6826141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Autism | 21865298 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6794600-6829200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:6822800-6830000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr8:6824600-6828200 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr8:6824800-6829200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr8:6826400-6826600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr8:6826400-6826800 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
7 | chr8:6826400-6826800 | Enhancers | Primary T cells fromperipheralblood | blood |
8 | chr8:6826400-6826800 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr8:6826400-6826800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr8:6826400-6827000 | Bivalent Enhancer | Primary B cells from peripheral blood | blood |
11 | chr8:6826600-6826800 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |